Even though Seattle Genetics applied for a trademark almost a year ago, I somehow missed it. Apparently their presumed blockbuster, SGN-35, is going to be marketed under the name ...
Adcetris.
To paraphrase Shakespeare, I suppose an identical drug by any other name would work as well. Either way the sooner this reaches the market, the better. I haven't seen any price estimates yet, but I imagine it won't be cheap.